Akero Clinical Study Site

Clinical research site in Madison, Wisconsin

As of July 2026, 2 paid clinical trials are recruiting at Akero Clinical Study Site in Madison, Wisconsin. Active studies at this site cover conditions such as NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis and NASH With Fibrosis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Akero Clinical Study Site (2)

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for NASH - Nonalcoholic Steatohepatitis

155 locations incl. Birmingham

Sponsor: Akero Therapeutics, Inc

Sex: All·Age: 18 - 80

Code: NCT06528314·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for NASH With Fibrosis

174 locations incl. Birmingham

Sponsor: Akero Therapeutics, Inc

Sex: All·Age: 18 - 80

Code: NCT06215716·Phase 3·Recruiting·Listed Jan 2024

Apply to this trial

More research sites in Madison

University of Wisconsin (111 trials)
University of Wisconsin Carbone Cancer Center - University Hospital (88 trials)
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center (57 trials)
University of Wisconsin - Madison (37 trials)
University of Wisconsin Carbone Cancer Center (29 trials)
University of Wisconsin-Madison (20 trials)
William S Middleton VA Medical Center (13 trials)
UW School of Medicine and Public Health (12 trials)
William S. Middleton Memorial Veterans Hospital, Madison, WI (12 trials)
UW Carbone Cancer Center (8 trials)

Explore more

Paid clinical trials in Madison, WI · Wisconsin clinical trials